Experienced in Continuous Spike-Wave During Slow Sleep Syndrome

Dr. Jaswinder P. Singh

Internal Medicine
Nassau Health Care Corporation
2201 Hempstead Tpke, 
East Meadow, NY 
Experienced in Continuous Spike-Wave During Slow Sleep Syndrome
Nassau Health Care Corporation
2201 Hempstead Tpke, 
East Meadow, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jaswinder Singh is a primary care provider, practicing in Internal Medicine in East Meadow, New York. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Continuous Spike-Wave During Slow Sleep Syndrome. His top areas of expertise are Alcoholic Cirrhosis, Sickle Cell Disease, End-Stage Renal Disease (ESRD), Gastrostomy, and Endoscopy.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in NY
Hospital Affiliations
Nassau University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CenterLight Healthcare
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

NASSAU HEALTH CARE CORPORATION
2201 Hempstead Tpke, East Meadow, NY 11554

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Fruquintinib
Study Phase: Phase 3
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 31, 2024
Intervention Type: Drug, Device
Study Drugs: Gemcitabine, Nab-paclitaxel
Study Phase: Phase 3
An Expanded Access Program of Surufatinib for Patients With Advanced or Metastatic Neuroendocrine Tumors
An Expanded Access Program of Surufatinib for Patients With Advanced or Metastatic Neuroendocrine Tumors
Enrollment Status: No_longer_available
Publish Date: April 12, 2024
Intervention Type: Drug
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
Enrollment Status: Terminated
Publish Date: February 05, 2024
Intervention Type: Drug
Study Drugs: VERU-111, Enzalutamide, Abiraterone, Darolutamide and Apalutamide
Study Phase: Phase 3
A Phase II Study of the Combination of LY3023414 and Necitumumab After First-Line Chemotherapy for Metastatic Squamous Non-small Cell Carcinoma of the Lung
A Phase II Study of the Combination of LY3023414 and Necitumumab After First-Line Chemotherapy for Metastatic Squamous Non-small Cell Carcinoma of the Lung
Enrollment Status: Terminated
Publish Date: December 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma
An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment Status: Completed
Publish Date: November 20, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain
A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain
Enrollment Status: Withdrawn
Publish Date: February 15, 2019
Intervention Type: Other, Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

15 Total Publications

Suspected Emphysematous Cellulitis of the Face Secondary to Untreated Nondisplaced Angle of the Mandible Fracture: A Case Report.
Suspected Emphysematous Cellulitis of the Face Secondary to Untreated Nondisplaced Angle of the Mandible Fracture: A Case Report.
Journal: Case reports in dentistry
Published: December 09, 2023
Similar Doctors
Advanced in Continuous Spike-Wave During Slow Sleep Syndrome
Dr. Ira M. Brooks
Internal Medicine
Advanced in Continuous Spike-Wave During Slow Sleep Syndrome
Dr. Ira M. Brooks
Internal Medicine

Jake Gurland, M.D

523 Broadway, 
Bayonne, NJ 
 (29.5 miles away)
201-649-1190
Experience:
43+ years
Languages Spoken:
English, Dutch
See accepted insurances
Accepting New Patients

Ira Brooks is a primary care provider, practicing in Internal Medicine in Bayonne, New Jersey. Dr. Brooks has been practicing medicine for over 43 years and is rated as an Advanced provider by MediFind in the treatment of Continuous Spike-Wave During Slow Sleep Syndrome. His top areas of expertise are Viral Gastroenteritis, Colitis, Chronic Inflammatory Response Syndrome (CIRS), Endoscopy, and Pacemaker Implantation. Dr. Brooks is currently accepting new patients.

Experienced in Continuous Spike-Wave During Slow Sleep Syndrome
Dr. Muhammed G. Ayub
Internal Medicine
Experienced in Continuous Spike-Wave During Slow Sleep Syndrome
Dr. Muhammed G. Ayub
Internal Medicine

Rwjbh Primary Care Services

166 Lyons Ave, 
Newark, NJ 
 (34.5 miles away)
732-229-2020
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Muhammed Ayub is a primary care provider, practicing in Internal Medicine in Newark, New Jersey. Dr. Ayub is rated as an Advanced provider by MediFind in the treatment of Continuous Spike-Wave During Slow Sleep Syndrome. His top areas of expertise are Osteomyelitis in Children, Type 1 Diabetes (T1D), Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Pacemaker Implantation.

Experienced in Continuous Spike-Wave During Slow Sleep Syndrome
Dr. David M. Chess
Geriatrics | Internal Medicine
Experienced in Continuous Spike-Wave During Slow Sleep Syndrome
Dr. David M. Chess
Geriatrics | Internal Medicine

Tapestry Telehealth PLLC

115 Dutch Lane Rd, 
Freehold, NJ 
 (48.6 miles away)
203-666-8145
Languages Spoken:
English, Castilian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

David Chess is a primary care provider, practicing in Geriatrics and Internal Medicine in Freehold, New Jersey. Dr. Chess is rated as a Distinguished provider by MediFind in the treatment of Continuous Spike-Wave During Slow Sleep Syndrome. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Heart Failure. Dr. Chess is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singh's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 119 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile